Y. Sumita

发表

New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet

T. Ochiya, S. Nagahara, H. Itoh, 1999, Nature Medicine.

Target of serine inhibition in Escherichia coli.

M. Tsuda, T. Tsuchiya, Y. Sumita, 1990, Biochemical and biophysical research communications.

Regulation of tetracycline accumulation in Bacillus subtilis bearing B. subtilis plasmid pNS1981

Y. Sumita, K. Shishido, 1985 .

In vitro synergistic activity between meropenem and other beta-lactams against methicillin-resistantStaphylococcus aureus

S. Mitsuhashi, Y. Sumita, 1991, European Journal of Clinical Microbiology and Infectious Diseases.

Affinities of SM-7338 for penicillin-binding proteins and its release from these proteins in Staphylococcus aureus

Y. Sumita, T. Okuda, M. Fukasawa, 1990, Antimicrobial Agents and Chemotherapy.

A new peptide ligand that targets particles and heterologous proteins to hepatocytes in vivo.

J. Wolff, J. Ludtke, M. G. Sebestyén, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

Comparison of two carbapenems, SM-7338 and imipenem: affinities for penicillin-binding proteins and morphological changes.

Y. Sumita, T. Okuda, M. Fukasawa, 1990, The Journal of antibiotics.

Structural features resulting in convulsive activity of carbapenem compounds: effect of C-2 side chain.

Y. Sumita, M. Sunagawa, H. Matsumura, 1995, The Journal of antibiotics.

Transient carbapenem resistance induced by salicylate in Pseudomonas aeruginosa associated with suppression of outer membrane protein D2 synthesis

Y. Sumita, M. Fukasawa, 1993, Antimicrobial Agents and Chemotherapy.

Stability of meropenem and effect of 1 beta-methyl substitution on its stability in the presence of renal dehydropeptidase I

Y. Sumita, T. Tanio, M. Sunagawa, 1992, Antimicrobial Agents and Chemotherapy.

Potent activity of meropenem against Escherichia coli arising from its simultaneous binding to penicillin-binding proteins 2 and 3.

Y. Sumita, M. Fukasawa, Yoshihiro Sumita, 1995, The Journal of antimicrobial chemotherapy.

Comparative study on the efficacy of AmBisome and Fungizone in a mouse model of pulmonary aspergillosis.

Y. Ueda, Y. Niki, Koichiro Yoshida, 2006, The Journal of antimicrobial chemotherapy.

Synthesis and antibacterial activity of novel carbapenems with a catechol or hydroxypyridone moiety.

Y. Sumita, A. Sasaki, M. Sunagawa, 1995, The Journal of antibiotics.

Synthesis and biological properties of a new series of anti-MRSA beta-lactams; 2-(thiazol-2-ylthio)carbapenems.

Y. Sumita, M. Sunagawa, H. Yamaga, 1997, Bioorganic & medicinal chemistry.

Structure-activity relationship of 1 beta-methyl-carbapenem to its antibacterial activity: effect of the C-2 side chain and the 1 beta-methyl group.

Y. Sumita, A. Sasaki, M. Sunagawa, 1996, The Journal of antibiotics.

Structure-activity relationships for interactions between carbapenems and β-lactamases

Y. Sumita, M. Sunagawa, H. Nouda, 1995 .

The effect of 1 beta-methyl substituent and the basicity in C-2 side chain in carbapenem antibiotics on the activity against Pseudomonas aeruginosa oprD2 and nalB mutants.

Y. Sumita, M. Sunagawa, H. Yamaga, 1995, The Journal of antibiotics.

Synthesis and biological properties of a new series of anti-MRSA β-lactams; 2-(thiazol-2′-ylthio)carbapenems

Y. Sumita, M. Sunagawa, H. Yamaga, 1994 .

In vitro antibacterial activity and beta-lactamase stability of the new carbapenem SM-7338

S. Mitsuhashi, Y. Sumita, M. Inoue, 1989, European Journal of Clinical Microbiology and Infectious Diseases.

Stability ofMeropenemandEffect of1,-Methyl Substitution on ItsStability inthePresence ofRenalDehydropeptidase I

Y. Sumita, T. Tanio, T. Okuda, 1992 .

Structure-activity relationships of 1 beta-methyl-carbapenems to antimicrobial activity: effect of C-6 substituent.

Y. Sumita, Y. Kitamura, A. Sasaki, 1997, The Journal of antibiotics.

Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus

Y. Sumita, M. Fukasawa, K. Kanazawa, 1995, Antimicrobial agents and chemotherapy.

Novel quaternary ammonium carbapenems: 1 beta-methyl-2-(5'-substituted pyrrolidinylthio) carbapenems.

Y. Sumita, A. Sasaki, M. Sunagawa, 1994, The Journal of antibiotics.

The effect of 1 beta-methyl and imidoyl substituents on the antipseudomonal activity of carbapenems.

Y. Sumita, Y. Eguchi, M. Sunagawa, 1993, The Journal of antibiotics.

Comparative studies on the efficacy of AmBisome and Fungizone in a mouse model of disseminated aspergillosis

Y. Ueda, Y. Niki, Koichiro Yoshida, 2004 .

Binding affinities of β-lactam antibodies for penicillin-binding protein 2' in methicillin-resistant Staphylococcus aureus

S. Mitsuhashi, Y. Sumita, M. Inoue, 1995 .

Binding affinities of beta-lactam antibodies for penicillin-binding protein 2' in methicillin-resistant staphylococcus aureus.

S. Mitsuhashi, Y. Sumita, M. Inoue, 1995, The Journal of antimicrobial chemotherapy.

Structure-activity relationships of carbapenems to the antagonism of the antipseudomonal activity of other beta-lactam agents and to the beta-lactamase inducibility in Pseudomonas aeruginosa: effects of 1beta-methyl group and C-2 side chain.

Y. Sumita, M. Sunagawa, K. Kanazawa, 1999, The Journal of antibiotics.

Synthesis and Biological Properties of a New Series of Anti‐MRSA β ‐Lactams; 2‐(Thiazol‐2′‐ylthio)carbapenems.

Y. Sumita, M. Sunagawa, H. Yamaga, 1995 .